Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-X-C motif chemokine receptor 2 | 0.445 | 0.923 | 1.4E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2003 | 2003 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2003 | 2003 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
C-C motif chemokine receptor 2 | 0.418 | 0.846 | 2.3E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2003 | 2003 | ||||||||
|
MHC class I polypeptide-related sequence B | 0.576 | 0.731 | 4.1E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2006 | 2006 | ||||||||
|
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 | 0.475 | 0.769 | 8.4E-14 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2011 | 2014 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.020 | None | 0.500 | 2 | 2 | 2013 | 2016 | ||||||||
|
complement factor H | 0.441 | 0.885 | 0.86 |
|
disease | 0.020 | None | 0.500 | 2 | 2 | 2013 | 2014 | ||||||||
|
GTP binding protein overexpressed in skeletal muscle | 0.467 | 0.769 | 1.2E-08 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2011 | 2014 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1997 | 2018 | ||||||||
|
interleukin 12 receptor subunit beta 2 | 0.608 | 0.692 | 1.6E-09 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2005 | 2014 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
disease | 0.080 | None | 0.875 | 8 | 4 | 1999 | 2018 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.080 | None | 0.875 | 8 | 1 | 2010 | 2018 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.190 | None | 0.909 | 11 | 3 | 1993 | 2015 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.100 | None | 0.917 | 12 | 1 | 1999 | 2017 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.100 | None | 0.917 | 12 | 2 | 2004 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 1.000 | 15 | 5 | 2003 | 2018 | ||||||||
|
laccase domain containing 1 | 0.700 | 0.423 | 1.2E-05 |
|
disease | 0.190 | None | 1.000 | 11 | 2 | 2009 | 2019 | ||||||||
|
solute carrier family 11 member 1 | 0.525 | 0.846 | 1.5E-19 |
|
disease | 0.390 | None | 1.000 | 10 | 0 | 1998 | 2016 | ||||||||
|
parkin RBR E3 ubiquitin protein ligase | 0.431 | 0.846 | 6.9E-07 |
|
disease | 0.100 | None | 1.000 | 10 | 1 | 2004 | 2019 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
disease | 0.380 | None | 1.000 | 8 | 2 | 2002 | 2019 | ||||||||
|
succinate dehydrogenase complex subunit D | 0.472 | 0.885 | 0.34 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2008 | 2020 | ||||||||
|
leucine rich repeat kinase 2 | 0.510 | 0.808 | 2.6E-30 |
|
disease | 0.080 | None | 1.000 | 8 | 2 | 2011 | 2017 | ||||||||
|
toll like receptor 1 | 0.496 | 0.808 | 5.9E-23 |
|
disease | 0.370 | None | 1.000 | 7 | 2 | 2007 | 2018 | ||||||||
|
parkin coregulated | 0.722 | 0.308 | 2.4E-07 |
|
disease | 0.070 | None | 1.000 | 7 | 3 | 2004 | 2013 |